Category: Molecular Medicine
-

Targeting Melanoma: How SR-4835, a CDK12 Inhibitor, Acts as a Molecular Glue to Degrade Cyclin K
Discover how the groundbreaking CDK12 inhibitor SR-4835 is revolutionizing melanoma treatment by acting as a molecular glue to target and degrade cyclin K. – by James
-

Unlocking the Secrets of BiO: The Future of Molecular Medicine Gatekeeping
Unlocking the mysteries of biology, ‘Gatekeeping at BiO’ delves into the pivotal mechanisms that regulate cellular function and their implications for advancing molecular medicine. – by Klaus
-

Unveiling the Impact of Rat Hepatitis E Virus on HIV Patients: A Molecular Medicine Insight
Discover the intriguing intersection of viral zoonosis and immunocompromised states in our latest deep dive into the prevalence and implications of Rat Hepatitis E virus (Rocahepevirus ratti) in individuals with HIV. – by James
-

New Leaf Spot Culprit Unveiled: Pestalotiopsis nanjingensis Targets Photinia in China
Discover the groundbreaking identification of Pestalotiopsis nanjingensis as the culprit behind leaf spots on Photinia × fraseri, marking a significant advancement in plant pathology and protection in China. – by Klaus
-

Unlocking the Molecular Mysteries: How Neurogenetics and Epigenetics Influence the Feeling of Loneliness
Explore the intricate dance between genes and environment as we unravel the neurogenetic and epigenetic layers that contribute to the complex emotion of loneliness. – by The Don
-

Revolutionizing Acid Sphingomyelinase Deficiency: 2-Year Triumphs with Olipudase Alfa in ASCEND Trial Extension
Discover the groundbreaking advancements in treating acid sphingomyelinase deficiency as adults experience significant health improvements over two years with olipudase alfa, an innovative therapy emerging from the ASCEND trial extension. – by Klaus
-

Unveiling CX-5461: The Powerful Chemotherapy Drug with Mutagenic Effects in Human Cells
Discover the unexpected side of cancer treatment as we delve into the mutagenic effects of the chemotherapeutic drug CX-5461 on human cells, a finding that could reshape our approach to chemotherapy. – by Klaus
-

Unlocking Breast Cancer Treatment: Targeting the NLRP3 Inflammasome Pathway in Immune-Stromal Cells
Discover how the latest breakthrough in breast cancer research is unveiling the NLRP3 inflammasome pathway as a promising target for innovative immunotherapy treatments. – by Klaus
-

Unlocking the Mystery: How Human APOBEC3B Expression in Mice Leads to RNA Editing and Fatal Consequences
Discover the surprising effects of human APOBEC3B gene expression in mice, a breakthrough study revealing the fine line between RNA editing and lethality. – by James